CAPOTEN PRODUCT SALES APPROACH $200 MIL. IN SECOND QUARTER ON 61% VOLUME INCREASE; SALES OF TAGAMET "STRONG," DYAZIDE "SOFT," SMITHKLINE REPORTS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".